New Lung Ventilation Strategies Guided by Transpulmonary Pressure in VV-ECMO for Severe ARDS
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 104
- 试验地点
- 1
- 主要终点
- Proportion weaned from VV-ECMO
研究概览
简要总结
Extracorporeal membrane oxygenation (ECMO) has been widely used in patients with severe acute respiratory distress syndrome (ARDS). But how to choose mechanical ventilation strategy is still not clear for severe ARDS patients supported by ECMO. Our previous work found that, compared to the traditional "lung rest" strategy, transpulmonary pressure guide new lung ventilation strategy can better maintain lung volume reduction lung collapse, atelectasis occurs. The severe ARDS patients receiving ECMO therapy were randomized divided into a new ventilation strategy group and the conventional ventilation strategy group. The new ventilation strategy is transpulmonary pressure guide ventilator setting method, and the conventional ventilation strategy is Extracorporeal Life Support Organization (ELSO) guide ventilation method. Compare the difference between the two groups of patients in lung injury, and explore the lung protection mechanism of new lung ventilation strategies guided by transpulmonary pressure. Our research group considered that transpulmonary pressure guide new lung ventilation strategy can provide more effective lung protection. And it will be further used in clinical work.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 65 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •ARDS cause reversible;
- •Pure oxygen is given, but PaO2/FiO2<80;
- •P(A-a)O2>600mmHg;
- •Murray score≥3.0;
排除标准
- •peak inspiratory pressure>30cmH2O;
- •high FiO2>0.8;
- •ventilation>7 days;
- •contraindication to heparinization;
- •non-reversible central nervous system injury
- •chronic disease with a short life expectancy
结局指标
主要结局
Proportion weaned from VV-ECMO
时间窗: After patients randomized grouping 60 days
Respiratory failure was alleviated and then ECMO withdrawal could be considered
次要结局
- 60-day mortality(After patients randomized grouping 60 days)
研究者
Rui Wang
Principal Investigator
Beijing Chao Yang Hospital
